Expand MBX Menu
MBX MENU

MBX Latest Press Releases

-- June 12, 2026 --

MBX Biosciences Announces One-Year Data Demonstrating Sustained Benefit of Once-Weekly Canvuparatide as a Potential PTH Replacement Therapy in Chronic Hypoparathyroidism Globe Newswire 7:00 AM

-- June 1, 2026 --

MBX Biosciences to Host Virtual Investor Event to Discuss Once-Weekly Canvuparatide Presentations at ENDO 2026 Globe Newswire 8:00 AM

-- May 26, 2026 --

MBX Biosciences to Present at the Jefferies 2026 Global Healthcare Conference in New York City Globe Newswire 8:00 AM

-- May 11, 2026 --

MBX Biosciences Provides Obesity Portfolio Update Including Initial Phase 1 Data for MBX 4291 Supporting Potential for Once-Monthly Dosing Globe Newswire 7:00 AM

-- May 7, 2026 --

MBX Biosciences Reports First Quarter 2026 Financial Results and Corporate Highlights Globe Newswire 8:00 AM
MBX Biosciences Announces Appointment of Mark Soued as Chief Commercial Officer and Inducement Grant Award Globe Newswire 7:00 AM

-- April 23, 2026 --

MBX Biosciences to Host In-Person and Virtual Obesity Day on May 11, 2026 to Discuss Expanding Obesity Portfolio Globe Newswire 8:00 AM

-- April 3, 2026 --

MBX Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:00 AM

-- March 12, 2026 --

MBX Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Highlights Globe Newswire 8:00 AM

-- March 10, 2026 --

MBX Biosciences Appoints Karen Basbaum as Chief Business Officer Globe Newswire 8:00 AM

-- March 9, 2026 --

CORRECTING & REPLACING -- MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism Globe Newswire 10:21 AM
MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism Globe Newswire 8:00 AM

-- February 23, 2026 --

MBX Biosciences to Participate in Upcoming March Investor Conferences Globe Newswire 8:00 AM

-- February 11, 2026 --

MBX Biosciences to Participate in Upcoming Investor Conferences Globe Newswire 8:00 AM

-- January 22, 2026 --

MBX Biosciences Appoints Laurie Stelzer to Board of Directors as Audit Committee Chair Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes